S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Roche Price Target, Predictions & Analyst Ratings

+0.61 (+1.39 %)
(As of 01/15/2021 08:27 PM ET)
Today's Range
Now: $44.56
50-Day Range
MA: $43.02
52-Week Range
Now: $44.56
Volume2.20 million shs
Average Volume2.68 million shs
Market Capitalization$305.17 billion
P/E Ratio17.54
Dividend Yield1.62%

Analyst Ratings

Roche (OTCMKTS:RHHBY) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
14 Wall Street analysts have issued ratings and price targets for Roche in the last 12 months. Their average twelve-month price target is $48.00, predicting that the stock has a possible upside of 7.72%. The high price target for RHHBY is $48.00 and the low price target for RHHBY is $48.00. There are currently 1 sell rating, 5 hold ratings, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
RHHBY Consensus Rating: BuyBuyBuyBuy
RHHBY Consensus Rating Score: 2.572.792.792.83
RHHBY Analyst Ratings: 1 Sell Rating(s)
5 Hold Rating(s)
7 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
RHHBY Consensus Price Target: $48.00$48.00$48.00$48.00
RHHBY Price Target Upside: 7.72% upside13.23% upside13.23% upside13.23% upside

Roche (OTCMKTS:RHHBY) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Roche (OTCMKTS:RHHBY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
1/15/2021Deutsche Bank AktiengesellschaftInitiated CoverageHold
1/12/2021UBS GroupReiterated RatingBuy
1/8/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight
1/4/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
9/29/2020Berenberg BankInitiated CoverageHold
9/28/2020Societe GeneraleReiterated RatingBuy
7/13/2020Sanford C. BernsteinInitiated CoverageOutperform
5/15/2020BarclaysReiterated RatingOverweight
5/13/2020Wolfe ResearchUpgradeMarket Perform ➝ Outperform
4/30/2020HSBCUpgradeReduce ➝ Hold
3/10/2020The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy
2/18/2020CitigroupUpgradeNeutral ➝ Buy
1/23/2020CowenInitiated CoverageBuy$48.00
12/23/2019Royal Bank of CanadaReiterated RatingOutperform
6/20/2019Liberum CapitalDowngradeBuy ➝ Hold
1/28/2019Credit Suisse GroupUpgradeUnderperform ➝ Neutral
1/28/2019ArgusInitiated CoverageBuy ➝ Buy
12/11/2018Jefferies Financial GroupReiterated RatingBuy ➝ Buy
9/10/2018Bank of AmericaDowngradeBuy ➝ Neutral
(Data available from 1/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.